The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pre-diagnosis dietary patterns and risk of multiple myeloma in the NIH-AARP cohort.
 
Richa Parikh
No Relationships to Disclose
 
Francesca Castro
No Relationships to Disclose
 
Jelyn C. Eustaquio
No Relationships to Disclose
 
Andriy Derkach
No Relationships to Disclose
 
Janine Joseph
No Relationships to Disclose
 
Alexander M. Lesokhin
Honoraria - ITeos Therapeutics; Janssen; Legend Biotech; Pfizer; Sanofi; Trillium Therapeutics
Consulting or Advisory Role - Pfizer; Trillium Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Janssen Oncology (Inst); Pfizer (Inst); Sanofi (Inst); Trillium Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Serametrix, Inc
 
Saad Zafar Usmani
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Celgene; Genentech; Gilead Sciences; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Merck; Takeda
Research Funding - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Merck; Pharmacyclics; Sanofi; Seagen; Skyline Diagnostics
 
Urvi A Shah
Honoraria - Association of Community Cancer Centers (ACCC); MashupMD; MJH Life Sciences; OncLive/MJH Life Sciences; Phillips Gilmore Oncology; RedMedEd
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Janssen Oncology; Sanofi
Research Funding - Celgene/Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Plantable (Inst)